Advanced inflammation and metabolic risk testing evaluating immune activation, cardiovascular markers, insulin resistance.
IL-6, TNF-α, IL-1β, IFN-γ – Evaluate immune signaling and chronic inflammatory activation.
Oxidized LDL, GlycA, Lp-PLA2 – Detect vascular inflammation and plaque-related risk.
Hemoglobin A1c, Fructosamine, HOMA-IR – Identify early blood sugar dysregulation and insulin resistance.
Inflammation is often hidden. This panel reveals root causes and risks.
Yes. An 8–12 hour fast is recommended for optimal metabolic and lipid-related markers.
Most results return within 7–14 business days.
GlycA is an advanced marker of chronic systemic inflammation associated with cardiovascular and metabolic disease risk.
These markers reflect immune system signaling and can reveal deeper inflammatory activity not captured by standard labs.
Yes. HOMA-IR, fructosamine, and A1c help identify metabolic dysfunction before diabetes develops.